ATE391917T1 - Automatisches verfahren zur quantitativen bestimmung und überwachung von exogenem hämoglobin in vollblut, blutplasma und blutserum - Google Patents
Automatisches verfahren zur quantitativen bestimmung und überwachung von exogenem hämoglobin in vollblut, blutplasma und blutserumInfo
- Publication number
- ATE391917T1 ATE391917T1 AT01112904T AT01112904T ATE391917T1 AT E391917 T1 ATE391917 T1 AT E391917T1 AT 01112904 T AT01112904 T AT 01112904T AT 01112904 T AT01112904 T AT 01112904T AT E391917 T1 ATE391917 T1 AT E391917T1
- Authority
- AT
- Austria
- Prior art keywords
- blood
- hemoglobin
- monitoring
- plasma
- exogeneous
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- G01N33/726—Devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21062500P | 2000-06-09 | 2000-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE391917T1 true ATE391917T1 (de) | 2008-04-15 |
Family
ID=22783622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01112904T ATE391917T1 (de) | 2000-06-09 | 2001-06-05 | Automatisches verfahren zur quantitativen bestimmung und überwachung von exogenem hämoglobin in vollblut, blutplasma und blutserum |
Country Status (6)
Country | Link |
---|---|
US (1) | US6623972B2 (de) |
EP (1) | EP1162461B8 (de) |
JP (1) | JP4694720B2 (de) |
AT (1) | ATE391917T1 (de) |
DE (1) | DE60133510T2 (de) |
ES (1) | ES2305014T3 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030027347A1 (en) * | 2001-05-25 | 2003-02-06 | Phyllis Shapiro | Automated method for correcting blood analysis parameter results affected by interference from exogenous blood substitutes in whole blood, plasma, and serum |
WO2006075966A1 (en) * | 2005-01-17 | 2006-07-20 | Gyros Patent Ab | A versatile flow path |
US8592219B2 (en) * | 2005-01-17 | 2013-11-26 | Gyros Patent Ab | Protecting agent |
US7790464B2 (en) * | 2006-05-04 | 2010-09-07 | Blaze Medical Devices, LLC | Blood hemolysis analyzer |
US8906309B2 (en) * | 2009-04-27 | 2014-12-09 | Abbott Laboratories | Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer |
US8906308B2 (en) * | 2010-01-15 | 2014-12-09 | Abbott Laboratories | Method for determining volume and hemoglobin content of individual red blood cells |
US10853819B2 (en) | 2011-04-14 | 2020-12-01 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US10445846B2 (en) | 2011-04-14 | 2019-10-15 | Elwha Llc | Cost-effective resource apportionment technologies suitable for facilitating therapies |
US8599009B2 (en) | 2011-08-16 | 2013-12-03 | Elwha Llc | Systematic distillation of status data relating to regimen compliance |
CN103315710A (zh) * | 2013-06-17 | 2013-09-25 | 无锡市第三人民医院 | 光电比色血液丢失计量笔及配套使用的引流瓶 |
EP2910926A1 (de) | 2014-02-19 | 2015-08-26 | F.Hoffmann-La Roche Ag | Verfahren und Vorrichtung zum Zuordnen einer Blutplasmaprobe |
RU2730438C2 (ru) | 2016-05-11 | 2020-08-21 | Нова Биомедикэл Корпорэйшн | Датчик SO2 цельной крови |
WO2019018403A1 (en) | 2017-07-18 | 2019-01-24 | Virtech Bio, Llc | BLOOD SUBSTITUTES COMPRISING HEMOGLOBIN AND METHODS OF MAKING |
GB2573126B (en) * | 2018-04-24 | 2022-11-09 | Entia Ltd | A method and apparatus for determining haemoglobin concentration |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234903A (en) * | 1989-11-22 | 1993-08-10 | Enzon, Inc. | Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute |
WO1994008641A1 (en) * | 1992-10-13 | 1994-04-28 | Baxter International Inc. | Hemodialysis monitoring system for hemodialysis machines |
US5416026A (en) * | 1993-10-04 | 1995-05-16 | I-Stat Corporation | Method for detecting the change in an analyte due to hemolysis in a fluid sample |
JP2001513892A (ja) | 1997-03-03 | 2001-09-04 | シーエムイー テレメトリクス インコーポレーテッド | 代用血液の測定方法および装置 |
US6114173A (en) * | 1997-04-03 | 2000-09-05 | Bayer Corporation | Fully automated method and reagent composition therefor for rapid identification and characterization of reticulocytes erythrocytes and platelets in whole blood |
JP3830613B2 (ja) * | 1997-04-18 | 2006-10-04 | シスメックス株式会社 | 血液中の白血球及びヘモグロビン濃度測定試薬 |
US5858794A (en) * | 1997-05-13 | 1999-01-12 | Bayer Corporation | Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers |
-
2001
- 2001-05-18 US US09/861,069 patent/US6623972B2/en not_active Expired - Lifetime
- 2001-06-05 DE DE60133510T patent/DE60133510T2/de not_active Expired - Lifetime
- 2001-06-05 EP EP01112904A patent/EP1162461B8/de not_active Expired - Lifetime
- 2001-06-05 ES ES01112904T patent/ES2305014T3/es not_active Expired - Lifetime
- 2001-06-05 AT AT01112904T patent/ATE391917T1/de not_active IP Right Cessation
- 2001-06-08 JP JP2001174275A patent/JP4694720B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2305014T3 (es) | 2008-11-01 |
JP4694720B2 (ja) | 2011-06-08 |
DE60133510T2 (de) | 2009-06-25 |
JP2002040029A (ja) | 2002-02-06 |
DE60133510D1 (de) | 2008-05-21 |
US20020012904A1 (en) | 2002-01-31 |
EP1162461A3 (de) | 2002-03-06 |
US6623972B2 (en) | 2003-09-23 |
EP1162461A2 (de) | 2001-12-12 |
EP1162461B8 (de) | 2008-06-18 |
EP1162461B1 (de) | 2008-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE391917T1 (de) | Automatisches verfahren zur quantitativen bestimmung und überwachung von exogenem hämoglobin in vollblut, blutplasma und blutserum | |
DE60315373D1 (de) | Vorrichtung und Verfahren zur Bestimmung der Konzentration von Analyten | |
DK0985930T3 (da) | Teststrimler til visuel bestemmelse af glucosekoncentrationen i blod | |
ATE539675T1 (de) | System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur | |
DE60228755D1 (de) | Verfahren und vorrichtung zur überwachung der analytkonzentration durch optischen nachweis | |
DE69801210T2 (de) | Verbesserte in vitro Verfahren, Testkits und Reagenzien zum Screening von Blutgerinnungsfehlern | |
ATE268477T1 (de) | Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit | |
ATE546734T1 (de) | Risikomarker für eine herzkreislaufkrankheit | |
ATE312550T1 (de) | Vorrichtung zur segmentären bioimpedanzmessung von einem dialysepatienten | |
DE60312258D1 (de) | Vorrichtung zur Abnahme von zu untersuchenden Blutproben z.B. zur Bestimmung des Glucosegehaltes | |
WO2004097429A3 (en) | Apociii and the treatmentand diagnosis of diabetes | |
DE69837709D1 (de) | Vorrichtung und verfahren zur bestimmung des analytpegels | |
DE69910007D1 (de) | Vorrichtung zum vorhersagen von physiologischen messwerten | |
ZA200202942B (en) | Elisa for VEGF. | |
ATE181599T1 (de) | Methode zur bestimmung von hämoglobinaddukten | |
Kulinna et al. | The effect of self-monitoring the INR on quality of anticoagulation and quality of life | |
ATE100150T1 (de) | Verfahren zur bestimmung von physiologisch wirksamen substanzen. | |
DE602005006633D1 (de) | Reagenziensatz zum Nachweis von Lupus-Antikoagulant. | |
BR9804648A (pt) | Monitorização da obediência do paciente ao tratamento e da biodisponibilidade de drogas pela desproteinização de fluidos corpóreos. | |
WO2002097391A3 (en) | Automated method of correcting for interference of mean cell hemoglobin concentration | |
ATE191976T1 (de) | Verfahren zum nachweis von knochen- und anderen bindegewebeerkrankungen in menschen und tieren | |
DE50101715D1 (de) | Verfahren zum nachweis von alpha-oxoaldehyden in vollblut, blutplasma und/oder serum eines patienten | |
EP1162457A3 (de) | Vielfach-Koagulationstestsystem und Verfahren zu seiner Anwendung | |
ATE314648T1 (de) | Diagnostisches verfahren für asthma | |
RU2426988C1 (ru) | Способ прогнозирования течения раннего послеоперационного периода после операции на артерии или артериях, выполненной по поводу облитерирующего атеросклероза артерий нижних конечностей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |